Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.
See also
- Lysergamides § Simplified or partial lysergamides
- LY-178210
- Bay R 1531 (LY-197206)
- LY-293284
References
